Bizcommunity on MSN
Aspen to launch Mounjaro for weight management in South Africa
Aspen Pharmacare said it had secured regulatory approval to market Eli Lilly's blockbuster diabetes and obesity drug, ...
Apple's strong Services growth, Eli Lilly's GLP-1 momentum, and Visa's digital expansion headline today's top stock reports.
Explore Eli Lilly’s role in Healthcare Stocks, S&P 500 companies, and its impact on market trends and the S&P 500 index.
Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts ...
Fundamentally, Eli Lilly represents a juggernaut in medical innovations. Recently, the company has taken a leadership role in ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Cheryl Fergison has revealed she's lost three stone on weight-loss injection Mounjaro - but says the so-called 'wonder drug' ...
A woman has warned of the 'side effect' that took her by surprise after using a popular weight drug. Weight loss jabs like Mounjaro are increasing in popularity in the US and around the world.
South Africa's Aspen Pharmacare said on Monday it had secured regulatory approval to market Eli Lilly's blockbuster diabetes ...
IP Group has highlighted the potential for future royalty revenues tied to breakthrough obesity drug candidates under ...
Should Omvoh’s Clinical Results and Innovation Drive a Rethink of Eli Lilly’s (LLY) Specialty Focus?
In recent days, Eli Lilly announced new long-term clinical data for Omvoh showing sustained efficacy and safety in ulcerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results